8FE3 image
Deposition Date 2022-12-05
Release Date 2023-02-01
Last Version Date 2024-06-19
Entry Detail
PDB ID:
8FE3
Title:
Structure of dengue virus (DENV2) in complex with prM12, an anti-PrM monoclonal antibody
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
10.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Envelope protein E
Chain IDs:C (auth: A), E (auth: C), K (auth: E)
Chain Length:394
Number of Molecules:3
Biological Source:Dengue virus type 2
Polymer Type:polypeptide(L)
Molecule:prM protein
Chain IDs:D (auth: B), F (auth: D), L (auth: F)
Chain Length:81
Number of Molecules:3
Biological Source:Dengue virus type 2
Polymer Type:polypeptide(L)
Molecule:prM12 Fab Heavy Chain
Chain IDs:A (auth: H), G (auth: M), I (auth: O)
Chain Length:227
Number of Molecules:3
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:prM12 Fab Light Chain
Mutations:X102A,X103A,X106A,X107A,X108A
Chain IDs:B (auth: L), H (auth: N), J (auth: P)
Chain Length:215
Number of Molecules:3
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
Proc.Natl.Acad.Sci.USA 120 e2218899120 e2218899120 (2023)
PMID: 36638211 DOI: 10.1073/pnas.2218899120

Abstact

Cleavage of the flavivirus premembrane (prM) structural protein during maturation can be inefficient. The contribution of partially mature flavivirus virions that retain uncleaved prM to pathogenesis during primary infection is unknown. To investigate this question, we characterized the functional properties of newly-generated dengue virus (DENV) prM-reactive monoclonal antibodies (mAbs) in vitro and using a mouse model of DENV disease. Anti-prM mAbs neutralized DENV infection in a virion maturation state-dependent manner. Alanine scanning mutagenesis and cryoelectron microscopy of anti-prM mAbs in complex with immature DENV defined two modes of attachment to a single antigenic site. In vivo, passive transfer of intact anti-prM mAbs resulted in an antibody-dependent enhancement of disease. However, protection against DENV-induced lethality was observed when the transferred mAbs were genetically modified to inhibit their ability to interact with Fcγ receptors. These data establish that in addition to mature forms of the virus, partially mature infectious prM+ virions can also contribute to pathogenesis during primary DENV infections.

Legend

Protein

Chemical

Disease

Primary Citation of related structures